
Journal of Medicinal Chemistry p. 1470 - 1476 (1990)
Update date:2022-08-04
Topics:
Cavalleri
Turconi
Tamborini
Occelli
Cietto
Pallanza
Scotti
Berti
Romano
Parenti
A series of derivatives of rifamycin P, an antibiotic produced by fermentation of a mutant strain of Nocardia mediterranea or by chemical modification of rifamycin S, have been prepared. The structures of these compounds were determined by 1H NMR, IR, UV, and LC/MS. Their in vitro and in vivo antibacterial activities in comparison with rifampicin and two other rifamycins under investigation were evaluated. The derivatives were more active than rifamycin P against Mycobacterium avium complex and other slowly and rapidly growing nontuberculous mycobacteria which frequently cause systemic infection in patients with AIDS. 2'-(Diethylamino)rifamycin P (P/DEA) appears suitable for further investigation.
View MoreContact:+86-27-67841589
Address:Add: 999 Gaoxin Road, Donghu New Technology Development Zone, Wuhan City, Hubei, China
Melone Pharmaceutical Co., ltd
Contact:+86-411 82593920, 82593631
Address:No 232, JInma Roda, Development Zone, Dalian, China
website:https://www.sinoshiny.com/products
Contact:+86-20-62802632;62802633
Address:Room 330 GIGCAS Building,No.511 Kehua Street,Tianhe District
Jinan YouCheng Pharmatech Co.,Ltd
Contact:+86-18653163205
Address:No.750, Shunhua Road, University Science Park, High-tech Zone, Jinan City
Beijing Century Richap Chemistry Co.,Ltd
Contact:+86- 010-64455497
Address:Guannan County, Lianyungang City, Jiangsu Province, China
Doi:10.1002/hlca.19560390524
(1956)Doi:10.1016/j.tet.2008.12.016
(2009)Doi:10.1021/jo00242a049
(1988)Doi:10.1039/c5cc03421c
(2015)Doi:10.1039/C39870000662
(1987)Doi:10.1021/ol802946p
(2009)